LIOTHYRONINE SOD 25 MCG TAB
For 30 tablets
Pharmacies pay
$8.82 filed
30 × $0.29408 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$12.59 filed
30 × $0.41962 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.4× estimated
Medicare paid 1.4× what pharmacies pay.
Part D averages every strength and form sold under “Liothyronine Sodium*” / “Liothyronine Sodium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$15.14 estimated
$8.82 + $1.32 (15%) + $5.00 fee per fill = $15.14
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
LIOTHYRONINE SOD 25 MCG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as liothyronine sodium.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Northstar Rx LLC and SIGMAPHARM LABORATORIES, LLC.
FDA’s Established Pharmacologic Class for it is l-Triiodothyronine.
The NADAC file of 2026-10-14 prices it under 10 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $8.82 for 30 tablets (30 × $0.29408 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| SIGMAPHARM LABORATORIES, LLC | 3 | $0.29408 per EA filed |
| Biocon Pharma Inc. | 1 | $0.29408 per EA filed |
| Dr. Reddy's Labratories Inc. | 1 | $0.29408 per EA filed |
| Mylan Pharmaceuticals Inc. | 1 | $0.29408 per EA filed |
| Northstar Rx LLC | 1 | $0.29408 per EA filed |
| Sun Pharmaceutical Industries, Inc. | 1 | $0.29408 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 1 | $0.29408 per EA filed |
| Zydus Pharmaceuticals (USA) Inc. | 1 | $0.29408 per EA filed |
All 10 NDCs, with labeler and price
- 00093-2178-01 · Teva Pharmaceuticals USA, Inc. · $0.29408 per EA · eff. 2026-09-23 filed
- 16714-0167-01 · Northstar Rx LLC · $0.29408 per EA · eff. 2026-09-23 filed
- 42794-0019-02 · SIGMAPHARM LABORATORIES, LLC · $0.29408 per EA · eff. 2026-09-23 filed
- 42794-0019-06 · SIGMAPHARM LABORATORIES, LLC · $0.29408 per EA · eff. 2026-09-23 filed
- 42794-0019-12 · SIGMAPHARM LABORATORIES, LLC · $0.29408 per EA · eff. 2026-09-23 filed
- 59762-1207-01 · Mylan Pharmaceuticals Inc. · $0.29408 per EA · eff. 2026-09-23 filed
- 62756-0590-88 · Sun Pharmaceutical Industries, Inc. · $0.29408 per EA · eff. 2026-09-23 filed
- 68382-0583-01 · Zydus Pharmaceuticals (USA) Inc. · $0.29408 per EA · eff. 2026-09-23 filed
- 70377-0115-12 · Biocon Pharma Inc. · $0.29408 per EA · eff. 2026-09-23 filed
- 75907-0001-01 · Dr. Reddy's Labratories Inc. · $0.29408 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name liothyronine sodium with LIOTHYRONINE SOD 25 MCG TAB.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CYTOMEL 5 MCG TABLET | $0.3857 per EA filed | $0.40006 per EA filed |
| CYTOMEL 25 MCG TABLET | $0.53303 per EA filed | $0.40006 per EA filed |
| LIOMNY 5 MCG TABLET | $0.2023 per EA filed | $0.41962 per EA filed |
| LIOMNY 25 MCG TABLET | $0.29408 per EA filed | $0.41962 per EA filed |
| LIOMNY 50 MCG TABLET | $0.36222 per EA filed | $0.41962 per EA filed |
| LIOTHYRONINE SOD 5 MCG TAB | $0.2023 per EA filed | $0.41962 per EA filed |
| LIOTHYRONINE SOD 25 MCG TAB this page | $0.29408 per EA filed | $0.41962 per EA filed |
| LIOTHYRONINE SOD 50 MCG TAB | $0.36222 per EA filed | $0.41962 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 10 NDCs’ NADAC prices is $0.29408 per EA filed.
Of the 17 other products in FDA’s l-Triiodothyronine class priced per EA, 14 have a higher middle NADAC price and 2 a lower one; 1 has the same. The one in the middle is CYTOMEL 25 MCG TABLET, at $0.53303 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $12.59 for 30 tablets, at an average of $0.41962 per EA in 2024 (2024-01-01 to 2024-12-31) for “Liothyronine Sodium*” and “Liothyronine Sodium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 748,503 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for LIOTHYRONINE SOD 25 MCG TAB labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Liothyronine Sodium* / Liothyronine Sodium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 32 NADAC NDCs the name join matched to it have an FDA route including ORAL.